BPC-157 and TB-500 are frequently stacked in research and clinical settings. Here is what published data shows and which blood markers to track.
Quick Summary BPC-157 and TB-500 (Thymosin Beta-4) are two of the most studied peptides in the healing and recovery category. Both were reclassified to Category 1 on February 27, 2026, meaning they are legally compoundable under physician prescription. This article covers what published research shows about how they work together and which biomarkers to track. Educational purposes only -- not medical advice.
BPC-157 is a 15 amino acid peptide derived from a protein found in gastric juice. Published mechanisms studied in research include upregulation of growth hormone receptor expression in tendon fibroblasts, promotion of angiogenesis in damaged tissue, modulation of nitric oxide synthesis, and interaction with dopaminergic and serotonergic systems.
See the [BPC-157 reconstitution calculator](https://myprotocolstack.com/calculators/bpc-157) for preparation reference.
TB-500 is a synthetic version of Thymosin Beta-4. Published mechanisms include sequestration of actin monomers promoting cell motility, upregulation of receptors involved in tissue repair, anti-inflammatory effects through cytokine pathways, and promotion of angiogenesis.
The research rationale for combining BPC-157 and TB-500 is complementary mechanisms: BPC-157 works primarily through growth hormone receptor pathways, while TB-500 works through actin regulation and cell migration. Animal model research consistently shows additive effects with the combination.
Track your recovery markers and protocol at [myprotocolstack.com/labs](https://myprotocolstack.com/labs).
Inflammatory Markers
Tissue Healing Markers
CBC
Tracks WBC count reflecting immune system activity and healing response.
On February 27, 2026, the FDA reclassified BPC-157, TB-500, and 12 other peptides back to Category 1. Both compounds now require a prescription from a licensed provider. Read the full breakdown at the [RFK peptide reclassification guide](https://myprotocolstack.com/blog/rfk-peptide-reclassification-2026).
Can BPC-157 and TB-500 be mixed in the same syringe?
This is a clinical question for your prescribing provider.
How long do research protocols typically run?
Published animal studies and clinical case series report protocol durations ranging from 4 to 16 weeks.
What blood work should I get before starting?
A baseline panel including CBC, CMP, hs-CRP, albumin, and a lipid panel provides a useful reference point.
Are there any contraindications studied in research?
Published research has not identified significant drug interactions, but human safety data is limited. Clinical guidance is essential.
Where can I get BPC-157 and TB-500 legally?
Post-reclassification, both require a prescription from a licensed provider, then fulfillment through a licensed compounding pharmacy.
*This article is for educational purposes only. It does not constitute medical advice.*
*Written by the MyProtocolStack team. Last updated: February 2026.*
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.
Start Free →